<DOC>
	<DOCNO>NCT01867918</DOCNO>
	<brief_summary>In study investigator include colo-rectal cancer ( CRC ) patient start last line standard palliative chemotherapy . Eligible patient include patient KRAS mutation start line KRAS wild type start line treatment . Standard treatment today patient chemotherapy median overall survival ( OS ) 10 month . The hypothesis local treatment addition systemic treatment increase time progression , progression free survival overall survival compare patient receive systemic chemotherapy . The investigator experience local treatment liver metastasis CRC patient side-effects treatment general minor , although gastric bleed observed stereotactic body radiation therapy .</brief_summary>
	<brief_title>LOTCOL Study : Local Treatment Colo-rectal Liver Met</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Histologically verify adenocarcinoma colon rectum Ambulatory ECOG performance status 02 At least 18 year age Nonresectable liver metastasis Progressive disease within 4 month 1.line chemotherapy KRAS mutant 2.line chemotherapy KRAS wild type patient 14 liver metastasis large diameter 6 cm CTscan Up 20 lesion liver 4 lesion large 4 cm The patient start 2./3 . line chemotherapy ( KRAS mutant/KRAS wt ) Laboratory value follow : ANC ³ 1.5 x 109/L Platelets ³ 100 x 109/L Hb ³ 9g/dL Creatinine £ 2x upper limit normal Bilirubin &lt; 2.0x upper limit normal ASAT ALAT £ 5x upper limit normal Albumin level &gt; 30 g/L INR &lt; 1.3 Signed inform consent expect cooperation patient treatment follow must obtain document accord ICH GCP , national/local regulation Previous treatment 2. 3. line chemotherapy ( KRAS mutant/KRAS wt ) History prior metastatic disease last 3 year History CNS bone metastases Significant cardiac medical illness would limit activity survival , severe congestive heart failure , unstable angina , serious cardiac arrhythmia Largest liver mets &gt; 6 cm , 4 liver lesion &gt; 4 cm Pulmonary mets &gt; 3 cm Lymph node mets &gt; 2.5 cm Chemotherapy/radiation therapy major surgery within last 4 week start treatment Any reason , opinion investigator , patient participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>